The Patent Finder

PharmaIN Corporation

Also on record
Records under this name other than the patents PharmaIN Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 15 patents it holds.

Showing 1 to 9 of 9 · Back to PharmaIN Corporation

PatentTitleStatus Expires Confidence
US 7,790,140Compositions for delivery of therapeutics and other materials, and methods of making and using the same
Term ended
Term ended Jan 26, 2026 · From the USPTO record
Term endedTerm ended Jan 26, 2026From the USPTO record
US 10,010,613Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same
Surrendered on reissue
Surrendered on reissue Oct 7, 2025 · From the USPTO record
Surrendered on reissueSurrendered on reissue Oct 7, 2025From the USPTO record
US 8,257,682Compositions for delivery of therapeutics and other materials
Term ended
Term ended Mar 22, 2024 · From the USPTO record
Term endedTerm ended Mar 22, 2024From the USPTO record
US 8,277,776Compositions for delivery of therapeutics and other materials
Term ended
Term ended Jan 12, 2024 · From the USPTO record
Term endedTerm ended Jan 12, 2024From the USPTO record
US 8,231,859Compositions for delivery of therapeutics and other materials
Term ended
Term ended Nov 24, 2023 · From the USPTO record
Term endedTerm ended Nov 24, 2023From the USPTO record
US 7,138,105Compositions for delivery of therapeutics and other materials, and methods of making and using the same
Term ended
Term ended Nov 20, 2023 · From the USPTO record
Term endedTerm ended Nov 20, 2023From the USPTO record
US 7,589,169Compositions for treatment with glucagon-like peptide, and methods of making and using the same
Term ended
Ended no later than Feb 27, 2023 · From the USPTO record
Term endedEnded no later than Feb 27, 2023From the USPTO record
US 7,635,463Compositions for delivery of therapeutics and other materials
Term ended
Ended no later than Feb 27, 2023 · From the USPTO record
Term endedEnded no later than Feb 27, 2023From the USPTO record
US 5,118,799Process for converting crystalline erythromycin ethylsuccinate into stable amorphous erythromycin ethylsuccinate
Term ended
Term ended no later than Jun 2, 2012 · Low confidence
Term endedTerm ended no later than Jun 2, 2012Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited